These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 37486603)

  • 1. GPCRs and fibroblast heterogeneity in fibroblast-associated diseases.
    Dwivedi NV; Datta S; El-Kersh K; Sadikot RT; Ganti AK; Batra SK; Jain M
    FASEB J; 2023 Aug; 37(8):e23101. PubMed ID: 37486603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting GPCR Signaling for Idiopathic Pulmonary Fibrosis Therapies.
    Haak AJ; Ducharme MT; Diaz Espinosa AM; Tschumperlin DJ
    Trends Pharmacol Sci; 2020 Mar; 41(3):172-182. PubMed ID: 32008852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing Designed Receptors Exclusively Activated by Designer Drug Chemogenetic Tools to Identify Beneficial G Protein-Coupled Receptor Signaling for Fibrosis.
    Zhang J; Vardy E; Muise ES; Wang TM; Visconti R; Vadlamudi A; Pinto S; Peier AM
    J Pharmacol Exp Ther; 2020 Nov; 375(2):357-366. PubMed ID: 32848074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complicated lives of GPCRs in cardiac fibroblasts.
    Mazarura GR; Dallagnol JCC; Chatenet D; Allen BG; Hébert TE
    Am J Physiol Cell Physiol; 2022 Sep; 323(3):C813-C822. PubMed ID: 35938678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine Receptor D1 Is Exempt from Transforming Growth Factor
    Gao AY; Diaz Espinosa AM; Nguyen BBN; Link PA; Meridew J; Jones DL; Gibbard DF; Tschumperlin DJ; Haak AJ
    J Pharmacol Exp Ther; 2023 Sep; 386(3):277-287. PubMed ID: 37024146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Insight into GPCR and G-Proteins as Cancer Drivers.
    Chaudhary PK; Kim S
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ancient Link between G-Protein-Coupled Receptors and C-Terminal Phospholipid Kinase Domains.
    van den Hoogen DJ; Meijer HJG; Seidl MF; Govers F
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-Translational Modifications of G Protein-Coupled Receptors Control Cellular Signaling Dynamics in Space and Time.
    Patwardhan A; Cheng N; Trejo J
    Pharmacol Rev; 2021 Jan; 73(1):120-151. PubMed ID: 33268549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases.
    Li N; Shan S; Li XQ; Chen TT; Qi M; Zhang SN; Wang ZY; Zhang LL; Wei W; Sun WY
    Front Immunol; 2021; 12():822345. PubMed ID: 35111168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation.
    Rahman MM; Islam MR; Mim SA; Sultana N; Chellappan DK; Dua K; Kamal MA; Sharma R; Emran TB
    Oxid Med Cell Longev; 2022; 2022():8425640. PubMed ID: 36187336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
    Kimura T; Singh S; Tanaka N; Umemura T
    Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR-mediated YAP/TAZ inactivation in fibroblasts via EPAC1/2, RAP2C, and MAP4K7.
    Choi KM; Haak AJ; Diaz Espinosa AM; Cummins KA; Link PA; Aravamudhan A; Wood DK; Tschumperlin DJ
    J Cell Physiol; 2021 Nov; 236(11):7759-7774. PubMed ID: 34046891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling.
    Marchese A; Trejo J
    Cell Signal; 2013 Mar; 25(3):707-16. PubMed ID: 23201781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into emergent signaling modes of G protein-coupled receptors.
    Sutkeviciute I; Vilardaga JP
    J Biol Chem; 2020 Aug; 295(33):11626-11642. PubMed ID: 32571882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1.
    Zmajkovicova K; Bauer Y; Menyhart K; Schnoebelen M; Freti D; Boucher M; Renault B; Studer R; Birker-Robaczewska M; Klenk A; Nayler O; Gatfield J
    PLoS One; 2020; 15(2):e0228195. PubMed ID: 32053631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.
    Lyu C; Ye Y; Lensing MM; Wagner KU; Weigel RJ; Chen S
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34343132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.
    Tang XL; Wang Y; Li DL; Luo J; Liu MY
    Acta Pharmacol Sin; 2012 Mar; 33(3):363-71. PubMed ID: 22367282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting GPCRs to treat cardiac fibrosis.
    Zhang H; Ren L; Shivnaraine RV
    Front Cardiovasc Med; 2022; 9():1011176. PubMed ID: 36277752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between G protein-coupled receptors and nanotechnology.
    Jiang Y; Li Y; Fu X; Wu Y; Wang R; Zhao M; Mao C; Shi S
    Acta Biomater; 2023 Oct; 169():1-18. PubMed ID: 37517621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.